joey, as I'm sure you noticed, there were a bunch
Post# of 1460
This chart shows the pumping operations pretty clearly. If I had a lot of time to waste I'd go back and find sample posts from each of those run-ups, but I imagine everyone reading THIS post probably saw it for themselves when it was happening
http://bigcharts.marketwatch.com/quickchart/q...amp;time=9
So it could be that there will not be any substantive news on the Alzheimer's trial for awhile and the stock will flatline or sag. BUT, and this is important:
don't forget that they could announce either:
commencement of animal studies on Parkinson's, using the Michael J. Fox Foundation grant;
or, developing the epilepsy drug which seemingly has been put on the back burner after the good preliminary animal test results.
Or, they could announce something like a deeper statistical analysis of the results on the Alz trial, or a partnership to expand the study, or ? ? ? ? ?
That's the problem with these small biotechs -- any kind of news can spike or tank them, and their news cycle is far less predictable than a big biotech.